BOSTON, MA – January 6, 2022 – Mass General Brigham and Bank of America today announced a partnership to expand access to leading healthcare technology and investment insights at the World Medical Innovation Forum held annually each spring in Boston. Bank of America will join with Mass General Brigham as presenting sponsor of the Forum, bringing together two leading organizations with extensive healthcare expertise to advance medical breakthroughs for patients and support Boston’s continued growth as a global biotech and investment hub.
The 2022 Forum, being held May 2-4 at the Westin Copley in Boston, will explore the promise of new gene and cell therapies (GCT), the challenges to their development, and investment and market dynamics. GCT is widely recognized as a transformational opportunity in medicine, with the potential to stop or slow the effects of disease by targeting it at the genetic level.
“Innovation is central to enhancing patient care now and, in the future,” said Anne Klibanski, MD, President and CEO, Mass General Brigham. “The collaboration with Bank of America will enhance our ability to more broadly engage innovators and those who work to ensure innovation is translated to patient care — clinicians, scientists, entrepreneurs, investors, government leaders and payors — and advance medical breakthroughs for millions of patients around the world.”
Forum speakers include CEOs of leading companies in the GCT and biotech fields, investors, entrepreneurs, Harvard clinicians and scientists, government officials and other key influencers. Senior Bank of America healthcare bankers and research analysts will be among the featured speakers. Recently confirmed speakers include Albert Bourla, CEO of Pfizer, Robert Bradway, CEO of Amgen, Marc Casper, CEO, Thermo Fisher Scientific, and Peter Marks, MD, PhD, Director, Center for Biologics, Evaluation and Research, FDA.
“Our corporate and investor clients will benefit from the expertise and perspective that Bank of America and Mass General Brigham can bring to our Boston conference,” said Brian Moynihan, Chairman and CEO of Bank of America. “We see the conference as a crossroad of science, technology, and investment capital that can lead to breakthrough medical advancements and solutions.”
Mass General Brigham is the nation’s largest academic research enterprise. Its 6,200 Harvard Medical School appointed faculty conduct more than $2 billion of life science research every year, and they have pioneered some of the most significant GCT therapies. Many of these leading investigators are featured on the Forum agenda, which covers GCT strategy, clinical opportunities, patient access, economic and investment considerations, regulatory frameworks, and manufacturing scalability, among other topics.
To find out more about the Forum, and to register, visit https://worldmedicalinnovation.org/. The Forum team will continue to monitor COVID-19 and event safety protocols. Updates regarding the event format will be shared in the coming months.
About the World Medical Innovation Forum
The World Medical Innovation Forum was established in 2015 in response to the intensifying transformation of health care and its impact on innovation. The Forum is rooted in the belief that no matter the magnitude of change, the center of health care needs to be a shared, fundamental commitment to collaborative innovation – industry and academia working together to improve patient lives.
About Mass General Brigham
Mass General Brigham is an integrated academic healthcare system, uniting great minds in medicine to make life-changing impact for patients in our communities and people around the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a non-profit organization that is committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. For more information, please visit massgeneralbrigham.org.
About Bank of America
Bank of America is one of the world’s leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 66 million consumer and small business clients with approximately 4,300 retail financial centers, approximately 17,000 ATMs, and award-winning digital banking with approximately 41 million active users, including approximately 32 million mobile users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 3 million small business households through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and approximately 35 countries. Bank of America Corporation stock (NYSE: BAC) is listed on the New York Stock Exchange. www.bankofamerica.com
Mass General Brigham
Tracy M. Doyle
Mass General Brigham Innovation
(M) 262 227 5514
Bank of America
Global Investment Banking and Global Markets, and Enterprise Media